Skip to main content
Erschienen in: Drug Safety 4/2015

01.04.2015 | Current Opinion

Empowering Consumers as Contributors for Health Product Safety: Lessons from the Philippines

verfasst von: Kenneth Hartigan-Go

Erschienen in: Drug Safety | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Empowering consumers to contribute to adverse drug reaction reporting seems a sensible innovation, particularly when traditional reports emanating from healthcare professionals are neither increasing nor improving. This work, inspired by an EU-FP7-funded project, describes an attempt by the Philippines to introduce a consumer reporting system through education and an online platform for reporting, and the lessons that were captured in the process. While participating consumers did not contribute to the adverse drug reporting process in the traditional sense as originally expected, the reports received by the drug regulatory agency revealed consumers’ concerns regarding health product legitimacy, quality and market claims, as well as the lack of available and accessible information. These reports led regulators to take action. Initial insights on consumer behavior are proposed for regulators and industry to consider in greater depth and how this may impact on consumers providing valued information that will promote other aspects of product safety.
Literatur
2.
3.
Zurück zum Zitat Christensen CM, Grossman JH, Hwang J. Integrating to make it happen. In: Christensen CM, Grossman JH, Hwang J, editors. The innovator’s prescription: a disruptive solution for health care. New York: McGraw-Hill; 2009. p. 183–220. Christensen CM, Grossman JH, Hwang J. Integrating to make it happen. In: Christensen CM, Grossman JH, Hwang J, editors. The innovator’s prescription: a disruptive solution for health care. New York: McGraw-Hill; 2009. p. 183–220.
4.
Zurück zum Zitat Hartigan-Go K. Challenges of drug risk communications in the Philippines. Drug Saf. 2012;35(11):995–1004.PubMed Hartigan-Go K. Challenges of drug risk communications in the Philippines. Drug Saf. 2012;35(11):995–1004.PubMed
5.
Zurück zum Zitat Van Hunsel F, Harmark L, Pal S, Olsson S, Van Grootheest K. Experiences with adverse drug reaction reporting by patients. Drug Saf. 2012;35(1):45–60.CrossRefPubMed Van Hunsel F, Harmark L, Pal S, Olsson S, Van Grootheest K. Experiences with adverse drug reaction reporting by patients. Drug Saf. 2012;35(1):45–60.CrossRefPubMed
6.
Zurück zum Zitat Hsiao W, Reich MR, Takemi T. Regulations. In: Roberts MJ, Hsiao W, Berman P, Reich MR, editors. Getting health reform right: a guide to improving performance and equity. Oxford: Oxford University Press; 2003. p. 247–80. Hsiao W, Reich MR, Takemi T. Regulations. In: Roberts MJ, Hsiao W, Berman P, Reich MR, editors. Getting health reform right: a guide to improving performance and equity. Oxford: Oxford University Press; 2003. p. 247–80.
7.
Zurück zum Zitat Bennis W, Goleman D, Biederman PW. Creating a culture of candor. In: Bennis W, Goleman D, O’Toole J, editors. Transparency: how leaders create a culture of candor. San Francisco (CA): Jossey-Bass; 2008. p. 1–43. Bennis W, Goleman D, Biederman PW. Creating a culture of candor. In: Bennis W, Goleman D, O’Toole J, editors. Transparency: how leaders create a culture of candor. San Francisco (CA): Jossey-Bass; 2008. p. 1–43.
12.
Zurück zum Zitat Hopkins DM, Kontnik LT, Turnage MT. Pharmaceuticals. In: Hopkins DM, Kontnik LT, Turnage MT, editors. Counterfeiting exposed. Hoboken (NJ): Wiley; 2003. p. 69–93. Hopkins DM, Kontnik LT, Turnage MT. Pharmaceuticals. In: Hopkins DM, Kontnik LT, Turnage MT, editors. Counterfeiting exposed. Hoboken (NJ): Wiley; 2003. p. 69–93.
13.
Zurück zum Zitat McAdams T, Neslund N, Zucker KD. Business, torts and product liability. In: McAdams T, Neslund N, Zucker KD, editors. Law, business and society. 10th ed. New York: McGraw-Hill; 2012. p. 282–330. McAdams T, Neslund N, Zucker KD. Business, torts and product liability. In: McAdams T, Neslund N, Zucker KD, editors. Law, business and society. 10th ed. New York: McGraw-Hill; 2012. p. 282–330.
14.
Zurück zum Zitat Rifkin E, Bouwer E. The physician’s and patient’s perspectives. In: Rifkin E, Bouwer E, editors. The illusion of certainty (health benefits and risks). Berlin: Springer; 2007. p. 167–87.CrossRef Rifkin E, Bouwer E. The physician’s and patient’s perspectives. In: Rifkin E, Bouwer E, editors. The illusion of certainty (health benefits and risks). Berlin: Springer; 2007. p. 167–87.CrossRef
15.
Zurück zum Zitat Frank RG. Behavioral economics and health economics. In: Diamond P, Vartiainen H, editors. Behavioral economics and its applications. Princeton: Princeton University Press; 2007. p. 195–234. Frank RG. Behavioral economics and health economics. In: Diamond P, Vartiainen H, editors. Behavioral economics and its applications. Princeton: Princeton University Press; 2007. p. 195–234.
16.
Zurück zum Zitat Mowen JC, Minor M. Information processing I: involvement and perception. In: Mowen JC, Minor M, editors. Consumer behavior. 5th ed. USA: Prentice Hall; 2000. p. 64–6. Mowen JC, Minor M. Information processing I: involvement and perception. In: Mowen JC, Minor M, editors. Consumer behavior. 5th ed. USA: Prentice Hall; 2000. p. 64–6.
17.
Zurück zum Zitat Van Hunsel F, ten Berge E, Borgsteede SD, et al. What motivates patients to report ADR? Ann Pharmacother. 2010;44:936–7.CrossRefPubMed Van Hunsel F, ten Berge E, Borgsteede SD, et al. What motivates patients to report ADR? Ann Pharmacother. 2010;44:936–7.CrossRefPubMed
18.
Zurück zum Zitat East R, Wright M, Vanhuele M. Consumer behaviour: applications in marketing. Thousand Oaks (CA): Sage Publishing; 2008. p. 166–90. East R, Wright M, Vanhuele M. Consumer behaviour: applications in marketing. Thousand Oaks (CA): Sage Publishing; 2008. p. 166–90.
21.
Zurück zum Zitat Van Hunsel F, van Puijenbroek E, de Jong-van den Berg LTW, et al. Media attention and influence on reporting odds ratio in disproportionality analysis: an example of patient reporting of statins. Pharmacoepidemiol Drug Saf. 2010;19:26–32.CrossRefPubMed Van Hunsel F, van Puijenbroek E, de Jong-van den Berg LTW, et al. Media attention and influence on reporting odds ratio in disproportionality analysis: an example of patient reporting of statins. Pharmacoepidemiol Drug Saf. 2010;19:26–32.CrossRefPubMed
22.
Zurück zum Zitat Kotler P, Roberto EL. The nature and role of social campaigns to change public behavior. In: Social marketing. New York: Free Press, Macmillan Inc.; 1989. p. 3–23. Kotler P, Roberto EL. The nature and role of social campaigns to change public behavior. In: Social marketing. New York: Free Press, Macmillan Inc.; 1989. p. 3–23.
23.
Zurück zum Zitat De Savigny D, Adam T, editors. Systems thinking for health systems strengthening. World Health Organization; 2009. p. 32. De Savigny D, Adam T, editors. Systems thinking for health systems strengthening. World Health Organization; 2009. p. 32.
24.
Zurück zum Zitat Goldfarb A, Ho TH, Amaldoss W, et al. Behavioral models of managerial decision-making. Mark Lett. 2012;23:405–21.CrossRef Goldfarb A, Ho TH, Amaldoss W, et al. Behavioral models of managerial decision-making. Mark Lett. 2012;23:405–21.CrossRef
Metadaten
Titel
Empowering Consumers as Contributors for Health Product Safety: Lessons from the Philippines
verfasst von
Kenneth Hartigan-Go
Publikationsdatum
01.04.2015
Verlag
Springer International Publishing
Erschienen in
Drug Safety / Ausgabe 4/2015
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI
https://doi.org/10.1007/s40264-015-0274-z

Weitere Artikel der Ausgabe 4/2015

Drug Safety 4/2015 Zur Ausgabe